Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Other Non-Current Liabilities: 2009-2012

Historic Other Non-Current Liabilities for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $31.1 million.

  • Lexicon Pharmaceuticals' Other Non-Current Liabilities fell 42.04% to $31.1 million in Q3 2012 from the same period last year, while for Sep 2012 it was $31.1 million, marking a year-over-year decrease of 42.04%. This contributed to the annual value of $55.1 million for FY2011, which is 13.04% up from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its Other Non-Current Liabilities stood at $31.1 million for Q3 2012, which was down 47.56% from $59.3 million recorded in Q2 2012.
  • Over the past 5 years, Lexicon Pharmaceuticals' Other Non-Current Liabilities peaked at $59.3 million during Q2 2012, and registered a low of $540,000 during Q2 2010.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Other Non-Current Liabilities value was $49.6 million (recorded in 2011), while the average stood at $41.3 million.
  • Per our database at Business Quant, Lexicon Pharmaceuticals' Other Non-Current Liabilities surged by 9,410.56% in 2011 and then plummeted by 42.04% in 2012.
  • Lexicon Pharmaceuticals' Other Non-Current Liabilities (Quarterly) stood at $616,000 in 2009, then surged by 7,819.32% to $48.8 million in 2010, then rose by 13.04% to $55.1 million in 2011, then crashed by 42.04% to $31.1 million in 2012.
  • Its Other Non-Current Liabilities was $31.1 million in Q3 2012, compared to $59.3 million in Q2 2012 and $57.2 million in Q1 2012.